Arsenic-induced axial skeletal (dysraphic) disorders.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000818:Animals; D001149:Arsenates / Q000633:toxicity; D001151:Arsenic / Q000494:pharmacology / Q000633:toxicity*; D001152:Arsenicals / Q000494:pharmacology; D018053:Arsenites; D002101:Cacodylic Acid / Q000494:pharmacology; D006224:Cricetinae; D020964:Embryo Loss / Q000139:chemically induced; D005260:Female; D005865:Gestational Age; D008658:Inactivation, Metabolic; D007668:Kidney / Q000002:abnormalities*; D008431:Maternal-Fetal Exchange; D009436:Neural Tube Defects / Q000139:chemically induced*; D011247:Pregnancy; D012886:Skull / Q000002:abnormalities*; D017670:Sodium Compounds; D013723:Teratogens
D001149:Arsenates; D001152:Arsenicals; D018053:Arsenites; D017670:Sodium Compounds; D013723:Teratogens; C017947:sodium arsenite; D002101:Cacodylic Acid; C020300:monomethylarsonic acid; D001151:Arsenic